Article
The impact of OPRM1's genetic polymorphisms on methadone maintenance treatment in opioid addicts: a systematic review.
Pharmacogenomics - 1 Jun 2018
Oueslati Bilel, Moula Olfa, Ghachem Rim
Abstract excerpt
AIM: Methadone is a long-acting opioid receptor agonist. It is prescribed to patients with opioid-related use disorders. The OPRM1 gene encodes for methadone's main receptor. It appears that polymorphisms in OPRM1 may affect the efficacy of methadone maintenance treatment (MMT). OBJECTIVE: Our purpose was to identify all relevant published papers dealing with the impact ofOPRM1's SNPs on MMT's efficacy and to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
